Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTEST trial in resectable stage IIIA(N2) NSCLC
2011-005267-24Phase 2Active
- Sponsor
- Innovative Sensor Technology IST AG
- Start
- Mar 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, docetaxel, vinorelbine, pemetrexed, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Innovative Sensor Technology IST AG. Started Mar 2012; status: active.
02
Drugs
cisplatindocetaxelvinorelbinepemetrexedgemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2011-005267-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005267-24.